News
5h
AllAfrica on MSNKenya to Roll Out Long-Acting Injectable HIV Prep Lenacapavir By Jan 2026Kenya is set to roll out the long-acting injectable HIV Pre-Exposure prophylaxis (PrEP) Lenacapavir by January 2026 following its approval by the World Health Organization.In a statement, Health ...
18h
AllAfrica on MSNSouth Africa Gets R520 Million to Buy the Twice-a-Year Anti-HIV Jab - But There's a SnagSA has accepted an offer of just over R520-million from the Global Fund to Fight Aids, TB and Malaria to buy the twice-a-year ...
A landmark breakthrough in HIV prevention — a scientific feat decades in the making — received final approval from the Food ...
WHO director general Tedros Adhanom Ghebreyesus says this new drug—which only needs to be injected twice a year—is the next ...
22h
AllAfrica on MSNRwanda in Talks to Get New HIV Injectable DrugA newly approved HIV prevention drug, lenacapavir, is set to be introduced in at least nine countries in early 2026, and ...
The FDA approval of lenacapavir as a form of preexposure prophylaxis (PrEP) is a major step for HIV prevention, but its ...
Despite the recent approval of lenacapavir as a twice yearly PrEP, there is still a need for choice in HIV prevention, argue ...
GENEVA, 15 July 2025–Lenacapavir–a long-acting, six-monthly injectable antiretroviral medicine manufactured by Gilead Sciences–is now recommended by the World Health Organization as an additional HIV ...
The World Health Organization (WHO) has included Gilead Sciences' twice-yearly formulation of lenacapavir for pre-exposure ...
The World Health Organization (WHO) has recommended the global use of injectable lenacapavir (LEN) twice a year to provide near-total ...
WHO releases new guidelines recommending injectable lenacapavir for HIV prevention: Geneva Wednesday, July 16, 2025, 10:00 Hrs [IST] The World Health Organization (WHO) released n ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results